1. Home
  2. ACNT vs XGN Comparison

ACNT vs XGN Comparison

Compare ACNT & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascent Industries Co.

ACNT

Ascent Industries Co.

N/A

Current Price

$13.59

Market Cap

132.4M

Sector

Industrials

ML Signal

N/A

Logo Exagen Inc.

XGN

Exagen Inc.

N/A

Current Price

$8.46

Market Cap

110.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ACNT
XGN
Founded
1945
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.4M
110.7M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
ACNT
XGN
Price
$13.59
$8.46
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $10.14
AVG Volume (30 Days)
24.1K
★ 273.4K
Earning Date
11-03-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 106.72
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$11.02
Revenue Next Year
N/A
$10.28
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.86
$2.59
52 Week High
$17.92
$12.23

Technical Indicators

Market Signals
Indicator
ACNT
XGN
Relative Strength Index (RSI) 31.30 58.90
Support Level $13.53 $7.81
Resistance Level $14.50 $8.89
Average True Range (ATR) 0.27 0.42
MACD -0.07 -0.07
Stochastic Oscillator 10.58 58.33

Price Performance

Historical Comparison
ACNT
XGN

About ACNT Ascent Industries Co.

Ascent Industries Co is a specialty chemicals company focused on the development, production, and distribution of tailored, performance-driven chemical solutions. Its customers are spread across energy, household, industrial and institutional (HII), personal care, coatings, adhesives, sealants and elastomers (CASE), agriculture, water treatment, pulp and paper, construction, automotive, and other industrial markets. The company's core product portfolio includes surfactants, defoamers, lubricating agents, flame retardants, and specialty intermediates, offered in both petroleum-based and bio-based formulations. Geographically, it generates maximum revenue from the United States, followed by Mexico, Canada, Honduras, Colombia, the Netherlands, Costa Rica, Japan, and other markets.

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Share on Social Networks: